Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 658

1.

Validation Study of an Operational Tolerance Signature in Korean Kidney Transplant Recipients.

Lee YH, Seo JW, Kim YG, Moon JY, Kim JS, Jeong KH, Kim BM, Kim KW, Yang CW, Kim CD, Park JB, Kim YH, Chung BH, Lee SH.

Immune Netw. 2018 Oct 23;18(5):e36. doi: 10.4110/in.2018.18.e36. eCollection 2018 Oct.

2.

Time to Disease Recurrence Is a Predictor of Metastasis and Mortality in Patients with High-risk Prostate Cancer Who Achieved Undetectable Prostate-specific Antigen Following Robot-assisted Radical Prostatectomy.

Kim DK, Koo KC, Lee KS, Hah YS, Rha KH, Hong SJ, Chung BH.

J Korean Med Sci. 2018 Oct 16;33(45):e285. doi: 10.3346/jkms.2018.33.e285. eCollection 2018 Nov 5.

3.

Identifying the genetic causes for prenatally diagnosed structural congenital anomalies (SCAs) by whole-exome sequencing (WES).

Leung GKC, Mak CCY, Fung JLF, Wong WHS, Tsang MHY, Yu MHC, Pei SLC, Yeung KS, Mok GTK, Lee CP, Hui APW, Tang MHY, Chan KYK, Liu APY, Yang W, Sham PC, Kan ASY, Chung BHY.

BMC Med Genomics. 2018 Oct 25;11(1):93. doi: 10.1186/s12920-018-0409-z.

4.

Prediction of biochemical failure using prostate-specific antigen half-life in patients with adverse pathologic features after radical prostatectomy.

Lee KS, Koo KC, Chung BH.

World J Urol. 2018 Oct 22. doi: 10.1007/s00345-018-2531-0. [Epub ahead of print]

PMID:
30350018
5.

The ARID1B spectrum in 143 patients: from nonsyndromic intellectual disability to Coffin-Siris syndrome.

van der Sluijs EPJ, Jansen S, Vergano SA, Adachi-Fukuda M, Alanay Y, AlKindy A, Baban A, Bayat A, Beck-Wödl S, Berry K, Bijlsma EK, Bok LA, Brouwer AFJ, van der Burgt I, Campeau PM, Canham N, Chrzanowska K, Chu YWY, Chung BHY, Dahan K, De Rademaeker M, Destree A, Dudding-Byth T, Earl R, Elcioglu N, Elias ER, Fagerberg C, Gardham A, Gener B, Gerkes EH, Grasshoff U, van Haeringen A, Heitink KR, Herkert JC, den Hollander NS, Horn D, Hunt D, Kant SG, Kato M, Kayserili H, Kersseboom R, Kilic E, Krajewska-Walasek M, Lammers K, Laulund LW, Lederer D, Lees M, López-González V, Maas S, Mancini GMS, Marcelis C, Martinez F, Maystadt I, McGuire M, McKee S, Mehta S, Metcalfe K, Milunsky J, Mizuno S, Moeschler JB, Netzer C, Ockeloen CW, Oehl-Jaschkowitz B, Okamoto N, Olminkhof SNM, Orellana C, Pasquier L, Pottinger C, Riehmer V, Robertson SP, Roifman M, Rooryck C, Ropers FG, Rosello M, Ruivenkamp CAL, Sagiroglu MS, Sallevelt SCEH, Sanchis Calvo A, Simsek-Kiper PO, Soares G, Solaeche L, Mujgan Sonmez F, Splitt M, Steenbeek D, Stegmann APA, Stumpel CTRM, Tanabe S, Uctepe E, Utine GE, Veenstra-Knol HE, Venkateswaran S, Vilain C, Vincent-Delorme C, Vulto-van Silfhout AT, Wheeler P, Wilson GN, Wilson LC, Wollnik B, Kosho T, Wieczorek D, Eichler E, Pfundt R, de Vries BBA, Clayton-Smith J, Santen GWE.

Genet Med. 2018 Nov 8. doi: 10.1038/s41436-018-0330-z. [Epub ahead of print]

PMID:
30349098
6.

Effects of age and comorbidity on survival vary according to risk grouping among patients with prostate cancer treated using radical prostatectomy: A retrospective competing-risk analysis from the K-CaP registry.

Hah YS, Lee KS, Choi IY, Lee JY, Hong JH, Kim CS, Lee HM, Hong SK, Byun SS, Lee SH, Rha KH, Chung BH, Koo KC.

Medicine (Baltimore). 2018 Oct;97(42):e12766. doi: 10.1097/MD.0000000000012766.

7.

Effect of Klotho on autophagy clearance in tacrolimus-induced renal injury.

Lim SW, Shin YJ, Luo K, Quan Y, Ko EJ, Chung BH, Yang CW.

FASEB J. 2018 Oct 11:fj201800751R. doi: 10.1096/fj.201800751R. [Epub ahead of print]

PMID:
30307767
8.

Robot-Assisted Partial Nephrectomy for Totally Endophytic Renal Tumors: Step by Step Standardized Surgical Technique and Long-Term Outcomes with a Median 59-Month Follow-Up.

Abdel Raheem A, Chang KD, Alenzi MJ, Lum TG, Ham WS, Han WK, Chung BH, Choi YD, Rha KH.

J Laparoendosc Adv Surg Tech A. 2018 Oct 9. doi: 10.1089/lap.2018.0124. [Epub ahead of print]

PMID:
30307365
9.

Clinical significance of the Kidney Donor Profile Index in deceased donors for prediction of post-transplant clinical outcomes: A multicenter cohort study.

Lee JH, Park WY, Kim YS, Choi BS, Park CW, Yang CW, Kim YS, Jin K, Han S, Chung BH.

PLoS One. 2018 Oct 5;13(10):e0205011. doi: 10.1371/journal.pone.0205011. eCollection 2018.

10.

Mosaic KRAS mutation in a patient with encephalocraniocutaneous lipomatosis and renovascular hypertension.

McDonell LM, Leung GK, Daoud H, Ip J, Chim S, Luk HM, Lan L; Care4Rare Canada Consortium, Boycott KM, Chung BH.

Am J Med Genet A. 2018 Oct 5. doi: 10.1002/ajmg.a.40349. [Epub ahead of print] No abstract available.

PMID:
30289595
11.

Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: A cross-sectional study.

Lim JH, Lee CH, Kim KY, Jung HY, Choi JY, Cho JH, Park SH, Kim YL, Baek MC, Park JB, Kim YH, Chung BH, Lee SH, Kim CD.

PLoS One. 2018 Sep 18;13(9):e0204204. doi: 10.1371/journal.pone.0204204. eCollection 2018.

12.

Rho-kinase/AMPK axis regulates hepatic lipogenesis during overnutrition.

Huang H, Lee SH, Sousa-Lima I, Kim SS, Hwang WM, Dagon Y, Yang WM, Cho S, Kang MC, Seo JA, Shibata M, Cho H, Belew GD, Bhin J, Desai BN, Ryu MJ, Shong M, Li P, Meng H, Chung BH, Hwang D, Kim MS, Park KS, Macedo MP, White M, Jones J, Kim YB.

J Clin Invest. 2018 Oct 29. pii: 63562. doi: 10.1172/JCI63562. [Epub ahead of print]

13.

Importance of androgen-deprivation therapy during enzalutamide treatment in men with metastatic castration-resistant prostate cancer following chemotherapy: results from retrospective, multicenter data.

Jeong CW, Kang M, Il Jung S, Kim TH, Park SW, Joung JY, Jeon SS, Hong JH, Lee JY, Chung BH, Ahn H, Kim CS, Kwon DD, Kwak C.

Prostate Cancer Prostatic Dis. 2018 Sep 13. doi: 10.1038/s41391-018-0088-z. [Epub ahead of print]

PMID:
30214035
14.

Prognostic Factors of Penile Cancer and the Efficacy of Adjuvant Treatment after Penectomy: Results from a Multi-institution Study.

Kim JW, Kim YS, Ko WJ, Choi YD, Hong SJ, Chung BH, Lee KS.

J Korean Med Sci. 2018 Jul 25;33(37):e233. doi: 10.3346/jkms.2018.33.e233. eCollection 2018 Sep 10.

15.

Healthcare burden of rare diseases in Hong Kong - adopting ORPHAcodes in ICD-10 based healthcare administrative datasets.

Chiu ATG, Chung CCY, Wong WHS, Lee SL, Chung BHY.

Orphanet J Rare Dis. 2018 Aug 28;13(1):147. doi: 10.1186/s13023-018-0892-5. Review.

16.

A recurrent de novo DYNC1H1 tail domain mutation causes spinal muscular atrophy with lower extremity predominance, learning difficulties and mild brain abnormality.

Chan SHS, van Alfen N, Thuestad IJ, Ip J, Chan AO, Mak C, Chung BH, Verrips A, Kamsteeg EJ.

Neuromuscul Disord. 2018 Sep;28(9):750-756. doi: 10.1016/j.nmd.2018.07.002. Epub 2018 Jul 20.

PMID:
30122514
17.

Exome sequencing for paediatric-onset diseases: impact of the extensive involvement of medical geneticists in the diagnostic odyssey.

Mak CC, Leung GK, Mok GT, Yeung KS, Yang W, Fung CW, Chan SH, Lee SL, Lee NC, Pfundt R, Lau YL, Chung BH.

NPJ Genom Med. 2018 Aug 6;3:19. doi: 10.1038/s41525-018-0056-5. eCollection 2018.

18.

Management of patients with advanced prostate cancer in the Asia Pacific region: 'real-world' consideration of results from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017.

Chiong E, Murphy DG, Akaza H, Buchan NC, Chung BH, Kanesvaran R, Khochikar M, Letran J, Lojanapiwat B, Ng CF, Ong T, Pu YS, Saad M, Schubach K, Türkeri L, Umbas R, Le Chuyen V, Williams S, Ye DW; ANZUP Cancer Trials Group, Davis ID.

BJU Int. 2018 Jul 18. doi: 10.1111/bju.14489. [Epub ahead of print] Review.

PMID:
30019467
19.

Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients.

Kim KW, Kim BM, Doh KC, Kim CD, Jeong KH, Lee SH, Yang CW, Chung BH.

PLoS One. 2018 Jul 16;13(7):e0200631. doi: 10.1371/journal.pone.0200631. eCollection 2018.

20.

Molecular diagnosis of severe combined immunodeficiency using whole-exome sequencing.

Yang WL, Lau YL, Lee PP, Chung BH, Yang J.

Hong Kong Med J. 2018 Jun;24 Suppl 3(3):15-17. No abstract available.

21.

Clinical significance of CCR7+CD8+ T cells in kidney transplant recipients with allograft rejection.

Kim KW, Kim BM, Doh KC, Cho ML, Yang CW, Chung BH.

Sci Rep. 2018 Jun 11;8(1):8827. doi: 10.1038/s41598-018-27141-6.

22.

Case Report of a Large Common Hepatic Artery Aneurysm.

Lee D, Chung BH, Heo SH, Park YJ, Kim DI.

Ann Vasc Surg. 2018 Oct;52:316.e11-316.e13. doi: 10.1016/j.avsg.2018.04.011. Epub 2018 Jun 8.

PMID:
29886208
23.

Clinical significance of Th17 cells in kidney transplantation.

Chung BH, Yang CW, Cho ML.

Korean J Intern Med. 2018 Sep;33(5):860-866. doi: 10.3904/kjim.2018.095. Epub 2018 May 31.

24.

Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.

Min JW, Lee H, Choi BS, Park CW, Yang CW, Kim YS, Choi YJ, Oh EJ, Chung BH.

Ann Lab Med. 2018 Sep;38(5):450-457. doi: 10.3343/alm.2018.38.5.450.

25.

Spinal Muscular Atrophy With Respiratory Distress Type 1-A Child With Atypical Presentation.

Chiu ATG, Chan SHS, Wu SP, Ting SH, Chung BHY, Chan AOK, Wong VCN.

Child Neurol Open. 2018 Apr 19;5:2329048X18769811. doi: 10.1177/2329048X18769811. eCollection 2018.

26.

A Deep Belief Network and Dempster-Shafer-Based Multiclassifier for the Pathology Stage of Prostate Cancer.

Kim JK, Choi MJ, Lee JS, Hong JH, Kim CS, Seo SI, Jeong CW, Byun SS, Koo KC, Chung BH, Park YH, Lee JY, Choi IY.

J Healthc Eng. 2018 Mar 19;2018:4651582. doi: 10.1155/2018/4651582. eCollection 2018.

27.

The effects of testosterone replacement on penile structure and erectile function after long-term castration in adult male rats.

Huh JS, Chung BH, Hong CH, Ryu JK, Kim JH, Han WK, Park KK.

Int J Impot Res. 2018 Jun;30(3):122-128. doi: 10.1038/s41443-017-0010-6. Epub 2018 May 4.

PMID:
29725076
28.

Impact of clinical trial participation on survival in patients with castration-resistant prostate cancer: a multi-center analysis.

Koo KC, Lee JS, Kim JW, Han KS, Lee KS, Kim DK, Ha YS, Rha KH, Hong SJ, Chung BH.

BMC Cancer. 2018 Apr 26;18(1):468. doi: 10.1186/s12885-018-4390-x.

29.

Williams-Beuren syndrome in diverse populations.

Kruszka P, Porras AR, de Souza DH, Moresco A, Huckstadt V, Gill AD, Boyle AP, Hu T, Addissie YA, Mok GTK, Tekendo-Ngongang C, Fieggen K, Prijoles EJ, Tanpaiboon P, Honey E, Luk HM, Lo IFM, Thong MK, Muthukumarasamy P, Jones KL, Belhassan K, Ouldim K, El Bouchikhi I, Bouguenouch L, Shukla A, Girisha KM, Sirisena ND, Dissanayake VHW, Paththinige CS, Mishra R, Kisling MS, Ferreira CR, de Herreros MB, Lee NC, Jamuar SS, Lai A, Tan ES, Ying Lim J, Wen-Min CB, Gupta N, Lotz-Esquivel S, Badilla-Porras R, Hussen DF, El Ruby MO, Ashaat EA, Patil SJ, Dowsett L, Eaton A, Innes AM, Shotelersuk V, Badoe Ë, Wonkam A, Obregon MG, Chung BHY, Trubnykova M, La Serna J, Gallardo Jugo BE, Chávez Pastor M, Abarca Barriga HH, Megarbane A, Kozel BA, van Haelst MM, Stevenson RE, Summar M, Adeyemo AA, Morris CA, Moretti-Ferreira D, Linguraru MG, Muenke M.

Am J Med Genet A. 2018 May;176(5):1128-1136. doi: 10.1002/ajmg.a.38672.

PMID:
29681090
30.

Retzius-sparing robot-assisted radical prostatectomy using the Revo-i robotic surgical system: surgical technique and results of the first human trial.

Chang KD, Abdel Raheem A, Choi YD, Chung BH, Rha KH.

BJU Int. 2018 Sep;122(3):441-448. doi: 10.1111/bju.14245. Epub 2018 May 27.

PMID:
29645348
31.

Functional and oncological outcomes of open, laparoscopic and robot-assisted partial nephrectomy: a multicentre comparative matched-pair analyses with a median of 5 years' follow-up.

Chang KD, Abdel Raheem A, Kim KH, Oh CK, Park SY, Kim YS, Ham WS, Han WK, Choi YD, Chung BH, Rha KH.

BJU Int. 2018 Oct;122(4):618-626. doi: 10.1111/bju.14250. Epub 2018 May 24.

PMID:
29645344
32.

Update of aristolochic acid nephropathy in Korea.

Ban TH, Min JW, Seo C, Kim DR, Lee YH, Chung BH, Jeong KH, Lee JW, Kim BS, Lee SH, Choi BS, Han JS, Yang CW.

Korean J Intern Med. 2018 Sep;33(5):961-969. doi: 10.3904/kjim.2016.288. Epub 2018 Mar 20.

33.

Serial Monitoring of Immune Markers Being Represented Regulatory T Cell/T Helper 17 Cell Ratio: Indicating Tolerance for Tapering Immunosuppression after Liver Transplantation.

Jhun J, Lee SH, Lee SK, Kim HY, Jung ES, Kim DG, Choi J, Bae SH, Yoon SK, Chung BH, Yang CW, Cho ML, Choi JY.

Front Immunol. 2018 Mar 1;9:352. doi: 10.3389/fimmu.2018.00352. eCollection 2018.

34.

Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study.

Lee KS, Koo KC, Chung BH.

World J Urol. 2018 Jul;36(7):1059-1065. doi: 10.1007/s00345-018-2224-8. Epub 2018 Mar 5.

PMID:
29508049
35.

A case of prenatal isolated talipes and 22q11.2 deletion syndrome-an important chromosomal disorder missed by noninvasive prenatal screening.

Cheung KW, Lai CWS, Mak CCY, Hui PW, Chung BHY, Kan ASY.

Prenat Diagn. 2018 Apr;38(5):376-378. doi: 10.1002/pd.5241. Epub 2018 Mar 13. No abstract available.

PMID:
29473648
36.

Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy.

Heo JE, Koo KC, Hong SJ, Park SU, Chung BH, Lee KS.

Yonsei Med J. 2018 Mar;59(2):219-225. doi: 10.3349/ymj.2018.59.2.219.

37.

The Impact of Preoperative α-Adrenergic Antagonists on Ureteral Access Sheath Insertion Force and the Upper Limit of Force Required to Avoid Ureteral Mucosal Injury: A Randomized Controlled Study.

Koo KC, Yoon JH, Park NC, Lee HS, Ahn HK, Lee KS, Kim DK, Cho KS, Chung BH, Hong CH.

J Urol. 2018 Jun;199(6):1622-1630. doi: 10.1016/j.juro.2017.09.173. Epub 2018 Feb 2.

PMID:
29410081
38.

Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.

Leung GKC, Luk HM, Tang VHM, Gao WW, Mak CCY, Yu MHC, Wong WL, Chu YWY, Yang WL, Wong WHS, Ma ACH, Leung AYH, Jin DY, Chan KYK, Allanson J, Lo IFM, Chung BHY.

Sci Rep. 2018 Feb 5;8(1):2421. doi: 10.1038/s41598-018-20894-0.

39.

Impact of metformin on serum prostate-specific antigen levels: Data from the national health and nutrition examination survey 2007 to 2008.

Park JS, Lee KS, Ham WS, Chung BH, Koo KC.

Medicine (Baltimore). 2017 Dec;96(51):e9427. doi: 10.1097/MD.0000000000009427.

40.

Mandibulofacial dysostosis Guion-Almeida type caused by novel EFTUD2 splice site variants in two Asian children.

Yu KPT, Luk HM, Gordon CT, Fung G, Oufadem M, Garcia-Barcelo MM, Amiel J, Chung BHY, Lo IFM, Tiong YT.

Clin Dysmorphol. 2018 Apr;27(2):31-35. doi: 10.1097/MCD.0000000000000214.

PMID:
29381487
41.

Subcutaneous Fat Distribution is a Prognostic Biomarker for Men with Castration Resistant Prostate Cancer.

Lee JS, Lee HS, Ha JS, Han KS, Rha KH, Hong SJ, Chung BH, Koo KC.

J Urol. 2018 Jul;200(1):114-120. doi: 10.1016/j.juro.2018.01.069. Epub 2018 Jan 31.

PMID:
29366641
42.

Changes in Clinical Characteristics of Patients with an Initial Diagnosis of Prostate Cancer in Korea: 10-Year Trends Reported by a Tertiary Center.

Heo JE, Ahn HK, Kim J, Chung BH, Lee KS.

J Korean Med Sci. 2018 Feb 5;33(6):e42. doi: 10.3346/jkms.2018.33.e42.

43.

Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms.

Shim KH, Kim TW, Chung BH, Lee SW, Park JK, Park K, Cheon J, Lee KS, Kim HJ, Seong DH, Oh SJ, Kim SW, Lee JY, Choo SH, Choi JB.

Investig Clin Urol. 2018 Jan;59(1):49-54. doi: 10.4111/icu.2018.59.1.49. Epub 2017 Dec 15.

44.

Effect of Conversion to CTLA4Ig on Tacrolimus-Induced Diabetic Rats.

Jin L, Lim SW, Jin J, Luo K, Ko EJ, Chung BH, Lin HL, Yang CW.

Transplantation. 2018 Apr;102(4):e137-e146. doi: 10.1097/TP.0000000000002048.

PMID:
29319618
45.

Risk and Management of Postoperative Urinary Retention Following Spinal Surgery.

Lee KS, Koo KC, Chung BH.

Int Neurourol J. 2017 Dec;21(4):320-328. doi: 10.5213/inj.1734994.497. Epub 2017 Dec 31.

46.

Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism.

Yeung KS, Tso WWY, Ip JJK, Mak CCY, Leung GKC, Tsang MHY, Ying D, Pei SLC, Lee SL, Yang W, Chung BH.

Mol Autism. 2017 Dec 20;8:66. doi: 10.1186/s13229-017-0182-4. eCollection 2017.

47.

Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients.

Kim MH, Lee YH, Seo JW, Moon H, Kim JS, Kim YG, Jeong KH, Moon JY, Lee TW, Ihm CG, Kim CD, Park JB, Chung BH, Kim YH, Lee SH.

PLoS One. 2017 Dec 21;12(12):e0190068. doi: 10.1371/journal.pone.0190068. eCollection 2017.

48.

Okur-Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion.

Chiu ATG, Pei SLC, Mak CCY, Leung GKC, Yu MHC, Lee SL, Vreeburg M, Pfundt R, van der Burgt I, Kleefstra T, Frederic TM, Nambot S, Faivre L, Bruel AL, Rossi M, Isidor B, Küry S, Cogne B, Besnard T, Willems M, Reijnders MRF, Chung BHY.

Clin Genet. 2018 Apr;93(4):880-890. doi: 10.1111/cge.13196. Epub 2018 Feb 13.

PMID:
29240241
49.

Usefulness of valacyclovir prophylaxis for cytomegalovirus infection after anti-thymocyte globulin as rejection therapy.

Ko EJ, Yu JH, Yang CW, Chung BH.

Korean J Intern Med. 2017 Dec 15. doi: 10.3904/kjim.2017.040. [Epub ahead of print]

50.

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.

Lee H, Park KH, Ryu JH, Choi AR, Yu JH, Lim J, Han K, Kim SI, Yang CW, Chung BH, Oh EJ.

PLoS One. 2017 Dec 12;12(12):e0189488. doi: 10.1371/journal.pone.0189488. eCollection 2017.

Supplemental Content

Loading ...
Support Center